🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.88
-0.10 (-1.43%)
Nov 20, 2026, 2:16 PM EST - Market open

Aura Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
39.8922.4922.8119.7618.0610.09
Research & Development
105.3590.373.365.2342.2425.16
Operating Expenses
145.23112.7996.1284.9960.335.25
Operating Income
-145.23-112.79-96.12-84.99-60.3-35.25
Interest & Investment Income
8.066.639.438.591.860.01
Other Non Operating Income (Expenses)
0.320.08-0.12-0.08-0.01-0.01
EBT Excluding Unusual Items
-136.86-106.08-86.81-76.48-58.45-35.25
Gain (Loss) on Sale of Assets
---0.21-0.32-0
Pretax Income
-136.86-106.08-86.81-76.27-58.76-35.25
Income Tax Expense
0.090.110.110.14--
Net Income
-136.95-106.19-86.92-76.41-58.76-35.25
Preferred Dividends & Other Adjustments
-----10.94
Net Income to Common
-136.95-106.19-86.92-76.41-58.76-46.19
Net Income Growth
------
Shares Outstanding (Basic)
85605040305
Shares Outstanding (Diluted)
85605040305
Shares Change
52.09%21.52%25.32%32.34%480.18%1305.21%
EPS (Basic)
-1.61-1.76-1.75-1.93-1.96-8.95
EPS (Diluted)
-1.61-1.76-1.75-1.93-1.96-8.95
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-109.68-85.19-81.06-64.56-55.7-34.54
Free Cash Flow Per Share
-1.29-1.41-1.63-1.63-1.86-6.69
EBITDA
-144.18-111.66-94.89-83.7-59.12-34.42
D&A For EBITDA
1.061.131.221.31.180.83
EBIT
-145.23-112.79-96.12-84.99-60.3-35.25
SEC Filings: 10-K · 10-Q